• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Fracture healing-orthobiologics: from basic science to clinical application.骨折愈合——骨生物制剂:从基础科学到临床应用
OTA Int. 2023 May 4;6(2 Suppl):e262. doi: 10.1097/OI9.0000000000000262. eCollection 2023 May.
2
Regulatory and Ethical Aspects of Orthobiologic Therapies.生物治疗的监管与伦理问题
Orthop J Sports Med. 2022 Nov 30;10(11):23259671221101626. doi: 10.1177/23259671221101626. eCollection 2022 Nov.
3
Utilization of Orthobiologics by Sports Medicine Physicians: A Survey-based Study.运动医学医师对矫形生物制剂的应用:一项基于调查的研究。
J Am Acad Orthop Surg Glob Res Rev. 2021 Jan 6;5(1):e20.00185. doi: 10.5435/JAAOSGlobal-D-20-00185.
4
Bone grafts, bone substitutes and orthobiologics: the bridge between basic science and clinical advancements in fracture healing.骨移植材料、骨替代物和骨生物制剂:基础科学与骨折愈合临床进展之间的桥梁。
Organogenesis. 2012 Oct-Dec;8(4):114-24. doi: 10.4161/org.23306. Epub 2012 Oct 1.
5
Current Trends in Orthobiologics: An 11-Year Review of the Orthopaedic Literature.当前的矫形生物制品趋势:对矫形文献的 11 年回顾。
Am J Sports Med. 2022 Sep;50(11):3121-3129. doi: 10.1177/03635465211037343. Epub 2021 Sep 16.
6
Human platelet lysate - A potent (and overlooked) orthobiologic.人血小板裂解物——一种强大(且被忽视)的再生医学产品。
J Clin Orthop Trauma. 2021 Jul 28;21:101534. doi: 10.1016/j.jcot.2021.101534. eCollection 2021 Oct.
7
The future of Cochrane Neonatal.考克兰新生儿协作网的未来。
Early Hum Dev. 2020 Nov;150:105191. doi: 10.1016/j.earlhumdev.2020.105191. Epub 2020 Sep 12.
8
Orthobiologics and platelet rich plasma.骨科生物制剂与富血小板血浆
Indian J Orthop. 2014 Jan;48(1):1-9. doi: 10.4103/0019-5413.125477.
9
Bone Marrow Mesenchymal Stem Cell Therapy and Related Bone Marrow-Derived Orthobiologic Therapeutics.骨髓间充质干细胞疗法及相关骨髓源性组织工程生物制品
Curr Rev Musculoskelet Med. 2019 Dec;12(4):451-459. doi: 10.1007/s12178-019-09583-1.
10
[Aiming for zero blindness].追求零失明
Nippon Ganka Gakkai Zasshi. 2015 Mar;119(3):168-93; discussion 194.

本文引用的文献

1
Effects of sclerostin antibody on bone healing.硬化蛋白抗体对骨愈合的影响。
World J Orthop. 2021 Sep 18;12(9):651-659. doi: 10.5312/wjo.v12.i9.651.
2
The critical role of Hedgehog-responsive mesenchymal progenitors in meniscus development and injury repair.Hedgehog 反应性间质祖细胞在半月板发育和损伤修复中的关键作用。
Elife. 2021 Jun 4;10:e62917. doi: 10.7554/eLife.62917.
3
Notch-Wnt signal crosstalk regulates proliferation and differentiation of osteoprogenitor cells during intramembranous bone healing.Notch-Wnt信号串扰在膜内骨愈合过程中调节骨祖细胞的增殖和分化。
NPJ Regen Med. 2021 May 28;6(1):29. doi: 10.1038/s41536-021-00139-x.
4
Osteoporosis Treatment with Anti-Sclerostin Antibodies-Mechanisms of Action and Clinical Application.抗硬化蛋白抗体治疗骨质疏松症——作用机制与临床应用
J Clin Med. 2021 Feb 16;10(4):787. doi: 10.3390/jcm10040787.
5
Targeting cartilage EGFR pathway for osteoarthritis treatment.靶向软骨表皮生长因子受体通路治疗骨关节炎。
Sci Transl Med. 2021 Jan 13;13(576). doi: 10.1126/scitranslmed.abb3946.
6
Bone marrow adipogenic lineage precursors promote osteoclastogenesis in bone remodeling and pathologic bone loss.骨髓脂肪生成系前体细胞促进骨重建和病理性骨丢失中的破骨细胞生成。
J Clin Invest. 2021 Jan 19;131(2). doi: 10.1172/JCI140214.
7
Romosozumab in Skeletally Mature Adults with a Fresh Unilateral Tibial Diaphyseal Fracture: A Randomized Phase-2 Study.用于骨骼成熟成人新鲜单侧胫骨骨干骨折的 Romosozumab:一项随机 2 期研究。
J Bone Joint Surg Am. 2020 Aug 19;102(16):1416-1426. doi: 10.2106/JBJS.19.01008.
8
A Randomized, Placebo-Controlled Study of Romosozumab for the Treatment of Hip Fractures.唑来膦酸治疗髋部骨折的随机、安慰剂对照研究。
J Bone Joint Surg Am. 2020 Apr 15;102(8):693-702. doi: 10.2106/JBJS.19.00790.
9
Drugs, Devices, and the FDA: Part 2: An Overview of Approval Processes: FDA Approval of Medical Devices.药物、器械与美国食品药品监督管理局:第二部分:审批流程概述:医疗器械的美国食品药品监督管理局审批
JACC Basic Transl Sci. 2016 Jun 27;1(4):277-287. doi: 10.1016/j.jacbts.2016.03.009. eCollection 2016 Jun.
10
An FDA Viewpoint on Unique Considerations for Medical-Device Clinical Trials.美国食品药品监督管理局关于医疗器械临床试验特殊考量的观点
N Engl J Med. 2017 Apr 6;376(14):1350-1357. doi: 10.1056/NEJMra1512592.

骨折愈合——骨生物制剂:从基础科学到临床应用

Fracture healing-orthobiologics: from basic science to clinical application.

作者信息

Johnson Joey P, Ahn Jaimo, Dirschl Douglas R, Wixted John J, Evans Andrew R

机构信息

Department of Orthopedic Surgery, Heersink School of Medicine, University of Alabama at Birmingham, Birmingham, AL.

Department of Orthopaedic Surgery, University of Michigan, Ann Arbor, MI.

出版信息

OTA Int. 2023 May 4;6(2 Suppl):e262. doi: 10.1097/OI9.0000000000000262. eCollection 2023 May.

DOI:10.1097/OI9.0000000000000262
PMID:37168028
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10166332/
Abstract

Orthopaedics as a field and a profession is fundamentally concerned with the treatment of musculoskeletal disease, in all of its many forms. Our collective understanding of the cellular mechanisms underlying musculoskeletal pathology resulting from injury continues to evolve, opening novel opportunities to develop orthobiologic treatments to improve care. It is a long path to move from an understanding of cellular pathology to development of successful clinical treatment, and this article proposes to discuss some of the challenges to achieving translational therapies in orthopaedics. The article will focus on challenges that clinicians will likely face in seeking to bring promising treatments forward to clinical practice and strategies for improving success in translational efforts.

摘要

骨科作为一个领域和专业,从根本上关注各种形式的肌肉骨骼疾病的治疗。我们对损伤导致的肌肉骨骼病理学潜在细胞机制的集体理解不断发展,为开发改善治疗的骨科生物治疗方法带来了新的机遇。从对细胞病理学的理解到成功的临床治疗开发是一条漫长的道路,本文旨在讨论骨科实现转化治疗面临的一些挑战。本文将重点关注临床医生在将有前景的治疗方法推向临床实践时可能面临的挑战,以及提高转化努力成功率的策略。